Dimitrios Doultsinos

4PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Health and ecological risk assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Aug 22, 2026
IRE1 activity is prognostic in localised and metastatic prostate cancer and affects epithelial lineage states.

|Aug 10, 2022
Spatially resolved clonal copy number alterations in benign and malignant tissue.

Andrew Erickson, Mengxiao He, Emelie Berglund

|Feb 02, 2021
Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges.

Dimitrios Doultsinos, Ian G Mills

|May 24, 2020
Peptidomimetic-based identification of FDA-approved compounds inhibiting IRE1 activity.

Dimitrios Doultsinos, Antonio Carlesso, Chetan Chintha

Pageof 1

Frequent Collaborators

3 joint publications

Ian G Mills

1 joint publications

Antonio Carlesso

1 joint publications

Chetan Chintha

1 joint publications

James C Paton

1 joint publications

Adrienne W Paton

1 joint publications

Afshin Samali

1 joint publications

Eric Chevet

1 joint publications

Leif A Eriksson

1 joint publications

Mengxiao He

1 joint publications

Maja Marklund

Frequent Collaborators

3 joint publications

Ian G Mills

1 joint publications

Antonio Carlesso

1 joint publications

Chetan Chintha

1 joint publications

James C Paton

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us